top of page

Currently Recruitng

Clinical Trials

Currently Recruiting

3D Scans

Jazz Pharmaceuticals 406:

A Phase 3/4, An Open-Label, Multicenter, Switch Study Evaluating Changes in Blood Pressure in Participants with Narcolepsy Switching from High Sodium Oxybate to XYWAV

Jazz Pharmaceuticals 407:

A Prospective, Open-Label, Single-Arm, Multicenter Study to Evaluate the Effect of Low Sodium Oxybate Oral-Solution (XYWAV) on Sleepiness, Polysomnography, and Functional Outcomes in Adult Participants Aged 18 to 75 Years With Idiopathic Hypersomnia or Narcolepsy

bottom of page